Medical Subject Headings

Last uploaded: January 31, 2024
Preferred Name

Ipilimumab

Synonyms

MDX010

Definitions

An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.

ID

http://purl.bioontology.org/ontology/MESH/D000074324

altLabel

MDX010

Anti CTLA 4 MAb Ipilimumab

Yervoy

MDX 010

Anti-CTLA-4 MAb Ipilimumab

MDX CTLA 4

Ipilimumab, Anti-CTLA-4 MAb

MDX-010

MDX-CTLA-4

AQL

AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR

cui

C1692339

C1691227

C3154308

C1367202

DC

1

definition

An anti-CTLA-4 ANTIGEN monoclonal antibody initially indicated for the treatment of certain types of metastatic MELANOMA. Its mode of actions may include blocking of CTLA-4 mediated inhibition of CYTOTOXIC T LYMPHOCYTES, allowing for more efficient destruction of target tumor cells.

DX

20180101

FX

D060908

HN

2018(2012)

Inverse of AQ

http://purl.bioontology.org/ontology/MESH/Q000097

http://purl.bioontology.org/ontology/MESH/Q000096

http://purl.bioontology.org/ontology/MESH/Q000627

http://purl.bioontology.org/ontology/MESH/Q000648

http://purl.bioontology.org/ontology/MESH/Q000493

http://purl.bioontology.org/ontology/MESH/Q000494

http://purl.bioontology.org/ontology/MESH/Q000276

http://purl.bioontology.org/ontology/MESH/Q000134

http://purl.bioontology.org/ontology/MESH/Q000266

http://purl.bioontology.org/ontology/MESH/Q000378

http://purl.bioontology.org/ontology/MESH/Q000008

http://purl.bioontology.org/ontology/MESH/Q000009

http://purl.bioontology.org/ontology/MESH/Q000032

http://purl.bioontology.org/ontology/MESH/Q000191

http://purl.bioontology.org/ontology/MESH/Q000302

http://purl.bioontology.org/ontology/MESH/Q000145

http://purl.bioontology.org/ontology/MESH/Q000737

http://purl.bioontology.org/ontology/MESH/Q000502

http://purl.bioontology.org/ontology/MESH/Q000506

http://purl.bioontology.org/ontology/MESH/Q000187

http://purl.bioontology.org/ontology/MESH/Q000235

http://purl.bioontology.org/ontology/MESH/Q000633

http://purl.bioontology.org/ontology/MESH/Q000652

http://purl.bioontology.org/ontology/MESH/Q000528

Inverse of RB

0

Inverse of RO

http://purl.bioontology.org/ontology/MESH/D060908

isa

http://purl.bioontology.org/ontology/MESH/D000082082

http://purl.bioontology.org/ontology/MESH/D000074322

LT

TRD

Machine permutation

2018; IPILIMUMAB was indexed under ANTIBODIES, MONOCLONAL, 2012-2017

MDA

20170711

MMR

20200228

MN

D12.776.124.790.651.114.224.060.798

D12.776.124.486.485.114.224.060.798

D12.776.377.715.548.114.224.200.798

notation

D000074324

PA

D000074322

D000082082

prefLabel

Ipilimumab

RR

6T8C155666

TERMUI

T668085

T668091

T000915139

T668086

T791808

T000915128

T668087

TH

FDA SRS (2017)

NLM (2006)

NLM (2018)

NLM (2011)

tui

T116

T129

T121

subClassOf

http://purl.bioontology.org/ontology/MESH/D061067

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/MSHFRE/D000074324 MSHFRE CUI
http://purl.bioontology.org/ontology/MSHFRE/D000074324 MSHFRE CUI
http://purl.bioontology.org/ontology/RXNORM/1094837 RXNORM CUI
http://purl.bioontology.org/ontology/NDDF/013688 NDDF CUI
http://purl.bioontology.org/ontology/PDQ/CDR0000038447 PDQ CUI
http://purl.bioontology.org/ontology/PDQ/CDR0000038447 PDQ CUI
http://purl.bioontology.org/ontology/MSHFRE/D000074324 MSHFRE CUI
http://purl.bioontology.org/ontology/PDQ/CDR0000038447 PDQ CUI
http://purl.bioontology.org/ontology/SCTSPA/704649006 SCTSPA CUI
http://purl.bioontology.org/ontology/SNOMEDCT/704649006 SNOMEDCT CUI
http://purl.bioontology.org/ontology/RXNORM/1094833 RXNORM CUI
http://purl.bioontology.org/ontology/SCTSPA/697995005 SCTSPA CUI
http://purl.bioontology.org/ontology/MSHFRE/D000074324 MSHFRE CUI
http://purl.bioontology.org/ontology/SNOMEDCT/697995005 SNOMEDCT CUI
http://purl.bioontology.org/ontology/ATC/L01FX04 ATC CUI
http://purl.bioontology.org/ontology/VANDF/4030653 VANDF CUI
http://purl.bioontology.org/ontology/PDQ/CDR0000038447 PDQ CUI
http://purl.bioontology.org/ontology/NDFRT/N0000182641 NDFRT CUI
http://purl.bioontology.org/ontology/NDDF/013688 NDDF LOOM
https://go.drugbank.com/drugs/DB06186 MDM LOOM
http://purl.bioontology.org/ontology/RXNORM/1094833 RXNORM LOOM
http://purl.jp/bio/4/id/201306028792112642 IOBC LOOM
http://purl.obolibrary.org/obo/DRON_00020050 PDRO LOOM
http://purl.obolibrary.org/obo/DRON_00020050 DRON LOOM
http://purl.obolibrary.org/obo/DRON_00020050 ODNAE LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000182641 ODAE LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/697995005 SNOMEDCT LOOM
http://purl.bioontology.org/ontology/ATC/L01FX04 ATC LOOM
http://purl.bioontology.org/ontology/VANDF/4030653 VANDF LOOM
http://purl.obolibrary.org/obo/NCIT_C2654 BERO LOOM
http://purl.bioontology.org/ontology/PDQ/CDR0000038447 PDQ LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C508317 RH-MESH LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000182641 NDFRT LOOM
http://www.phoc.org.cn/pmo/class/PMO_00022047 PMAPP-PMO LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2654 NCIT LOOM